| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1145 |
| 1 | ADALIMUMAB | 969 |
| 2 | PREDNISONE | 952 |
| 3 | METHOTREXATE | 936 |
| 4 | ETANERCEPT | 726 |
| 5 | PREDNISOLONE | 675 |
| 6 | PREDNISOLONE ORAL | 675 |
| 7 | PREDNISOLONE ORAL SOLUTION | 675 |
| 8 | RITUXIMAB | 505 |
| 9 | FOLIC ACID | 365 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRANACOGENE DEZAPARVOVEC | 7 | 0.1077 |
| 1 | NEOSTIGMINE METHYLSULFATE | 9 | 0.0209 |
| 2 | INFLIXIMAB-DYYB | 51 | 0.0148 |
| 3 | ERGOCALCIFEROL | 311 | 0.0105 |
| 4 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 5 | 0.0103 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 74 | 0.0089 |
| 6 | BRODALUMAB | 16 | 0.0078 |
| 7 | DINUTUXIMAB | 6 | 0.0070 |
| 8 | BARICITINIB | 21 | 0.0069 |
| 9 | PSYLLIUM HUSK | 9 | 0.0067 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2189 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1239 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 932 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 857 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 771 |
| 5 | Vitamin C [EPC] | 472 |
| 6 | Kinase Inhibitor [EPC] | 419 |
| 7 | Proton Pump Inhibitor [EPC] | 413 |
| 8 | Vitamin B12 [EPC] | 413 |
| 9 | Alkylating Drug [EPC] | 403 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 16 | 0.0078 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 6 | 0.0055 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 19 | 0.0043 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 14 | 0.0043 |
| 4 | Rifamycin Antimycobacterial [EPC] | 13 | 0.0037 |
| 5 | Oxytocic [EPC] | 11 | 0.0036 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 65 | 0.0034 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 41 | 0.0031 |
| 8 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 7 | 0.0028 |
| 9 | Purine Antimetabolite [EPC] | 269 | 0.0027 |